Ovarian CanceRx | Partners

Collaboration is Key

Ovarian CanceRx is a unique approach to clinical trials made possible by the partnership and collaboration of clinicians, researchers, regulators, pharmaceutical/biotech companies, patient advocacy groups, and patients. Together, we are making progress in bringing new treatment options to patients.

ADVOCACY PARTNERS

5

Ovarian cancer accounts for 5% of all cancer death in women

90

Cases detected early have a +90% survival rate after 5 years

45

Women with BRCA1 gene mutation have a 45% lifetime risk of ovarian cancer

Ovarian CanceRx
Rapid. Adaptive. Needed.
In the Fight Against Advanced Ovarian Cancer.

Partner With Us